Alternative Investment Funds
Switzerland
12 September 2024
Wenger Vieli Ltd is well-equipped to assist with mandates concerning the de-listing of reimbursed products, M&A, and product liability claims. Frank Scherrer leads the team with his longstanding expertise in establishment licences, marketing authorisations, and data protection issues. Marcel Boller is a key contact for pharma companies and pharmacies seeking advice on data exclusivity issues and joint ventures.
Legal 500 Editorial commentary
Work highlights
Advising a global pharmaceutical company in relation to the introduction by the regulator of turnover based rebates.
Represented a pharmaceutical company in appeal proceedings regarding the deletion of one of its products from the list of reimbursed products.
Advised IK Partners on the EUR 370m sale of Klingel medical metal group to Elos Medtech.
Lawyers
Practice head
Frank Scherrer
Other key lawyers
Marcel Boller